Skip to main content
. 2019 Sep 27;10:4397. doi: 10.1038/s41467-019-12292-5

Fig. 1.

Fig. 1

miR-574-5p and miR-574-3p were reversely expressed in GC patients. a The predicted secondary structure of miR-219, miR-369 and miR-574 precursors. b, c The expression changes of three pairs of miRNA arms: miR-219-5p/-3p, miR-369-5p/-3p, and miR-574-5p/-3p in GC tissues. d The reversed expression of miR-574-5p/-3p in GC patients. e Correlation of miR-574-5p/-3p expression with clinical pathological characteristics of GC patients. f, g Correlation of miR-574-5p/-3p expression with TNM stages of GC patients. The center line indicates the median expression level, bounds of box indicates the interquartile range and whiskers indicates the maximum and minimum value (f). A risk factor was defined as miR-574-5p upregulation or miR-574-3p downregulation (g). h Kaplan–Meier survival analysis showed the correlation of arm-imbalance of miR-574 with survival rate of GC patients. Data are shown as means ± s.d.